Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting

被引:42
作者
DiLuigi, Andrea J. [1 ]
Engmann, Lawrence [1 ]
Schmidt, David W. [1 ]
Maier, Donald B. [1 ]
Nulsen, John C. [1 ]
Benadiva, Claudio A. [1 ]
机构
[1] Univ Connecticut Hlth Ctr, Ctr Adv Reprod Serv, Div Reprod Endocrinol & Infertil, Farmington, CT 06030 USA
关键词
GnRH agonist; GnRH antagonist; OHSS; high responder; IN-VITRO FERTILIZATION; HUMAN CHORIONIC-GONADOTROPIN; GNRH ANTAGONIST GANIRELIX; EMBRYO-TRANSFER; FOLLICULAR MATURATION; INVITRO FERTILIZATION; SYNDROME OHSS; OVULATION; IVF; CYCLES;
D O I
10.1016/j.fertnstert.2009.10.034
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ninety-four women undergoing IVF with peak E-2 level>4000 pg/mL received leuprolide acetate (LA) trigger (LA trigger group) or had gonadotropins withheld for one or more days (coasting group) followed by hCG trigger, unless cycle cancellation occurred. There were no cases of ovarian hyperstimulation syndrome in either group, and the LA trigger group had significantly more oocytes retrieved (26.9 +/- 9.5 vs. 17.7 +/- 9.3) P<0.001, more normally fertilized oocytes (15.0 +/- 7.8 vs. 10.3 +/- 6.3) P=0.01, and higher clinical and ongoing pregnancy rates than the coasting group (52.5% vs. 27.2%; 49.2% vs. 24.2%, P=0.02 for both comparisons, respectively). (Fertil Steril (R) 2010;94:1111-4. (C)2010 by American Society for Reproductive Medicine.)
引用
收藏
页码:1111 / 1114
页数:4
相关论文
共 52 条
[21]   Withholding gonadotropins ("coasting") to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles [J].
Fluker, MR ;
Hooper, WM ;
Yuzpe, AA .
FERTILITY AND STERILITY, 1999, 71 (02) :294-301
[22]   Coasting for the prevention of ovarian hyperstimulation syndrome:: much ado about nothing? [J].
García-Velasco, JA ;
Isaza, V ;
Quea, G ;
Pellicer, A .
FERTILITY AND STERILITY, 2006, 85 (03) :547-554
[23]  
GARCIAVELASCO JA, 2004, HUM REPROD, V9, P500
[24]  
Golan A, 1989, Obstet Gynecol Surv, V44, P430, DOI 10.1097/00006254-198906000-00004
[25]   GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis [J].
Griesinger, G ;
Diedrich, K ;
Devroey, P ;
Kolibianakis, EM .
HUMAN REPRODUCTION UPDATE, 2006, 12 (02) :159-168
[26]   Correctly timed coasting reduces the risk of ovarian hyperstimulation syndrome and gives good cycle outcome in an in vitro fertilization program [J].
Grochowski, D ;
Wolczynski, S ;
Kuczynski, W ;
Domitrz, J ;
Szamatowicz, J ;
Szamatowicz, M .
GYNECOLOGICAL ENDOCRINOLOGY, 2001, 15 (03) :234-238
[27]   Coasting vs. cryopreservation of all embryos for prevention of ovarian hyperstimulation syndrome in in vitro fertilization [J].
Huddleston, Heather G. ;
Racowsky, Catherine ;
Jackson, Katharine V. ;
Fox, Janis H. ;
Ginsburg, Elizabeth S. .
FERTILITY AND STERILITY, 2008, 90 (04) :1259-1262
[28]   GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles:: a prospective randomized study [J].
Humaidan, P ;
Bredkjær, HE ;
Bungum, L ;
Bungum, M ;
Grondahl, ML ;
Westergaard, L ;
Andersen, CY .
HUMAN REPRODUCTION, 2005, 20 (05) :1213-1220
[29]   Oocyte and embryo quality after coasting:: the experience from oocyte donation [J].
Isaza, V ;
García-Velasco, JA ;
Aragonés, M ;
Remohí, J ;
Simón, C ;
Pellicer, A .
HUMAN REPRODUCTION, 2002, 17 (07) :1777-1782
[30]   Combined approach as an effective method in the prevention of severe ovarian hyperstimulation syndrome [J].
Isik, AZ ;
Vicdan, K .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 97 (02) :208-212